Komori
StemCell Institute (7096) · PolicyRestated

Policy of prioritizing retained earnings and considering dividends in the future

First written in FY2021. 9 of 12 entries say "Restated". Latest entry: FY2026.

12entries
6years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY2024-Q3AdvancedFY2025-H1 – FY20252021: 120212022: 220222023: 420232024: 220242025: 120252026: 22026
Same theme, other companies
No-dividend policy prioritizing business efficiency improvements and investment for expansionA theme 239 companies write about · 46 as a headwind · 167 as a tailwind

128 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 241 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Except for the dividend commemorating the company's 25th anniversary paid in the fiscal year of the 26th business year, the company did not pay dividends through the fiscal year of the 27th business year because it prioritized strengthening retained earnings to expand the scale of its business and strengthen its management base.」

    Except for the commemorative dividend in the 26th business year, the company returned to paying no dividends in the 27th business year and continued its policy of allocating retained earnings to stabilizing its business base and expanding its business.
  2. 2026-05-13RestatedEarnings

    「Fiscal year ended March 2026 — 0.00 — 0.00 0.00 — — — Fiscal year ending March 2027 (Forecast) — 0.00 — 0.00 0.00 —」

    Annual dividends are ¥0 for the fiscal year ended March 2026 and the forecast fiscal year ending March 2027.
  3. FY2025AchievedAnnual report

    「Dividends of surplus for which the record date falls within the fiscal year are as follows.」

    The company moved away from its policy of paying no dividends while prioritizing retained earnings and paid a 25th-anniversary commemorative dividend of ¥25 per share, totaling ¥256.163 million.
  4. FY2025-H1AdvancedAnnual report

    「The per-share dividend for the 26th business year will be a dividend commemorating the company's 25th anniversary.」

    The company moved away from its policy of continuing to pay no dividends through the previous filing and decided to pay a dividend of ¥25 per share to commemorate its 25th anniversary. The total dividend amount is stated as ¥256.163 million, with the effective date being 29 November 2024.
  5. FY2024-Q3RestatedAnnual report

    「The dividend per share is not stated because our company does not pay dividends.」

    The company did not pay a dividend for the cumulative third quarter.
  6. FY2024-Q2RestatedAnnual report

    「The dividend per share is not stated because our company does not pay dividends.」

    The Company did not pay dividends during the cumulative second quarter.
  7. FY2024-Q1RestatedAnnual report

    「The dividend per share is not stated because our company does not pay dividends.」

    The company did not pay dividends during the first quarter cumulative period either.
  8. FY2023RestatedAnnual report

    「Through the fiscal year of the 24th business year, the company did not pay dividends because it prioritized strengthening retained earnings to expand the scale of its business and strengthen its management base. However, the company regards returning profits to shareholders through dividends as an important management issue and plans to pay dividends going forward while taking into account the stabilization of its business base, financial position and operating results.」

    The company restated its policy of continuing to pay no dividends through the fiscal year of the 24th business year and allocating retained earnings to stabilizing its business base and expanding its business.
  9. FY2023-Q3RestatedAnnual report

    「The dividend per share is not stated because our company does not pay dividends.」

    The company has not paid dividends during the cumulative third quarter of the current fiscal year either.
  10. FY2023-Q1RestatedAnnual report

    「The dividend per share is not stated because our company does not pay dividends.」

    The company did not pay dividends during the cumulative first-quarter period. This filing does not restate the detailed policy of prioritizing retained earnings and considering dividends in the future.
  11. FY2022RestatedAnnual report

    「Through the fiscal year of the 23rd business year, the company did not pay dividends because it prioritized strengthening retained earnings to expand the scale of its business and strengthen its management base. However, the company regards returning profits to shareholders through dividends as an important management issue and plans to pay dividends going forward while taking into account the stabilization of its business base, financial position and operating results.」

    The company stated that it would continue paying no dividends through the end of the current business year and allocate retained earnings to stabilizing its business base and investing in business expansion.
  12. FY2021First statedAnnual report

    「Through the fiscal year of the 22nd business year, the company did not pay dividends because it prioritized strengthening retained earnings to expand the scale of its business and strengthen its management base. However, the company regards returning profits to shareholders through dividends as an important management issue and plans to pay dividends going forward while taking into account the stabilization of its business base, financial position and operating results.」

    The company has paid no dividends through the current fiscal year. It plans to allocate retained earnings to capital investment and business expansion and consider dividends in the future.
Moved together

"Increase in the Annual Number of Stored Specimens and Improvement in the Equity Ratio" moved the same way as this thread, in the same document, in 2 of its 12 moves.

222222★123456
  1. ★This thread
  2. 1Increase in the Annual Number of Stored Specimens and Improvement in the Equity Ratio2×
  3. 2Business expansion into cells derived from umbilical cord and other perinatal tissues2×
  4. 3Launch of Umbilical Cord Tissue Storage Service2×
  5. 4Support for Clinical Research in Regenerative Medicine and Cell Therapy Using Umbilical Cord Blood2×
  6. 5Overseas business expansion focused on Asia2×
  7. 6Raising Awareness through Web Marketing and Local Sales2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for StemCell Institute yet. It last moved in the Earnings of 2026-05-13: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.